Tvardi Therapeutics, Inc. (TVRD)
4.53
+0.24
(+5.59%)
USD |
NASDAQ |
Dec 10, 16:00
4.50
-0.03
(-0.66%)
After-Hours: 06:45
Tvardi Therapeutics EPS Diluted (Quarterly): -0.5894 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Novavax, Inc. | -1.246 |
| Precigen, Inc. | -1.059 |
| Xencor, Inc. | -0.081 |
| Denali Therapeutics, Inc. | -0.736 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.527M |
| Total Expenses (Quarterly) | 5.527M |
| Enterprise Value | 6.265M |
| Earnings Yield | -217.5% |
| Normalized Earnings Yield | -242.05 |